Actinogen Medical Limited (ACW.AX)
AUD 0.03
(3.85%)
AUD 0.03
(3.85%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 22.77 Million AUD | 47.22% |
| 2023 | 15.46 Million AUD | 21.1% |
| 2022 | 12.77 Million AUD | 131.51% |
| 2021 | 5.51 Million AUD | -35.09% |
| 2020 | 8.49 Million AUD | -43.14% |
| 2019 | 14.94 Million AUD | 62.36% |
| 2018 | 9.2 Million AUD | 117.3% |
| 2017 | 4.23 Million AUD | -41.28% |
| 2016 | 7.21 Million AUD | 29.31% |
| 2015 | 5.57 Million AUD | 798.9% |
| 2014 | 620.7 Thousand AUD | 35.7% |
| 2013 | 457.39 Thousand AUD | -60.62% |
| 2012 | 1.16 Million AUD | 4.64% |
| 2011 | 1.1 Million AUD | 5.34% |
| 2010 | 1.05 Million AUD | 15.81% |
| 2009 | 909.76 Thousand AUD | 53.8% |
| 2008 | 591.53 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 22.77 Million AUD | 47.22% |
| 2024 Q2 | 12.35 Million AUD | 0.0% |
| 2024 Q4 | 10.42 Million AUD | 0.0% |
| 2023 Q2 | 8.28 Million AUD | 0.0% |
| 2023 FY | 15.46 Million AUD | 21.1% |
| 2023 Q4 | 7.18 Million AUD | 0.0% |
| 2022 Q2 | 5.6 Million AUD | 0.0% |
| 2022 FY | 12.77 Million AUD | 131.51% |
| 2022 Q4 | 7.17 Million AUD | 0.0% |
| 2021 Q4 | 3.33 Million AUD | 0.0% |
| 2021 Q2 | 2.18 Million AUD | 0.0% |
| 2021 FY | 5.51 Million AUD | -35.09% |
| 2020 Q4 | 3.94 Million AUD | 0.0% |
| 2020 FY | 8.49 Million AUD | -43.14% |
| 2020 Q2 | 4.55 Million AUD | 0.0% |
| 2019 Q4 | 7.08 Million AUD | 0.0% |
| 2019 FY | 14.94 Million AUD | 62.36% |
| 2019 Q2 | 7.2 Million AUD | 0.0% |
| 2018 Q2 | 3.83 Million AUD | 0.0% |
| 2018 FY | 9.2 Million AUD | 117.3% |
| 2018 Q4 | 5.68 Million AUD | 0.0% |
| 2017 Q2 | 1.92 Million AUD | 0.0% |
| 2017 FY | 4.23 Million AUD | -41.28% |
| 2017 Q4 | 2.67 Million AUD | 0.0% |
| 2016 Q2 | 2.57 Million AUD | 0.0% |
| 2016 Q4 | 5 Million AUD | 0.0% |
| 2016 FY | 7.21 Million AUD | 29.31% |
| 2015 Q4 | 4.23 Million AUD | 0.0% |
| 2015 FY | 5.57 Million AUD | 798.9% |
| 2015 Q2 | 1.34 Million AUD | 0.0% |
| 2014 FY | 620.7 Thousand AUD | 35.7% |
| 2014 Q4 | 300.39 Thousand AUD | 0.0% |
| 2014 Q2 | 320.3 Thousand AUD | 0.0% |
| 2013 FY | 457.39 Thousand AUD | -60.62% |
| 2013 Q4 | 151.2 Thousand AUD | 134.97% |
| 2013 Q3 | 64.35 Thousand AUD | -79.16% |
| 2013 Q2 | 308.75 Thousand AUD | 189.1% |
| 2013 Q1 | 106.8 Thousand AUD | 0.0% |
| 2012 Q4 | 106.8 Thousand AUD | 0.0% |
| 2012 Q1 | 97.72 Thousand AUD | 0.0% |
| 2012 Q2 | 106.8 Thousand AUD | 9.29% |
| 2012 FY | 1.16 Million AUD | 4.64% |
| 2012 Q3 | 106.8 Thousand AUD | 0.0% |
| 2011 Q3 | 97.72 Thousand AUD | 0.0% |
| 2011 FY | 1.1 Million AUD | 5.34% |
| 2011 Q4 | 97.72 Thousand AUD | 0.0% |
| 2011 Q2 | 97.72 Thousand AUD | -3.4% |
| 2011 Q1 | 101.16 Thousand AUD | 0.0% |
| 2010 Q1 | 54.79 Thousand AUD | 0.0% |
| 2010 FY | 1.05 Million AUD | 15.81% |
| 2010 Q4 | 101.16 Thousand AUD | 0.0% |
| 2010 Q3 | 101.16 Thousand AUD | 0.0% |
| 2010 Q2 | 101.16 Thousand AUD | 84.61% |
| 2009 FY | 909.76 Thousand AUD | 53.8% |
| 2009 Q1 | 14.64 Thousand AUD | 0.0% |
| 2009 Q2 | 54.79 Thousand AUD | 274.31% |
| 2009 Q3 | 54.79 Thousand AUD | 0.0% |
| 2009 Q4 | 54.79 Thousand AUD | 0.0% |
| 2008 FY | 591.53 Thousand AUD | 0.0% |
| 2008 Q4 | 14.64 Thousand AUD | 0.0% |
| 2008 Q3 | 14.64 Thousand AUD | 0.0% |
| 2008 Q2 | 14.64 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | -236.369% |
| Acrux Limited | 8.55 Million AUD | -166.322% |
| AnteoTech Limited | 12.18 Million AUD | -86.842% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -175.367% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -111.126% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -3106.132% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 2.718% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -169.929% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -400.958% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -724.715% |
| Biome Australia Limited | 7.91 Million AUD | -187.825% |
| Biotron Limited | 5.11 Million AUD | -345.548% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -3683.606% |
| BTC Health Limited | -1.03 Million AUD | 2291.732% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -15.193% |
| CSL Limited | 7.56 Billion AUD | 99.699% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 59.56% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 27.244% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -104.705% |
| Dimerix Limited | 25.64 Million AUD | 11.203% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 42.462% |
| Hexima Limited | 1 Million AUD | -2157.298% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -451.964% |
| Immuron Limited | 9.13 Million AUD | -149.187% |
| Immutep Limited | 42.87 Million AUD | 46.891% |
| Imugene Limited | 135.09 Million AUD | 83.144% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -580.553% |
| Memphasys Limited | 3.67 Million AUD | -519.036% |
| Nanollose Limited | 12.5 Thousand AUD | -182049.388% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 30.359% |
| Noxopharm Limited | 7 Million AUD | -225.284% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -1058.674% |
| Nyrada Inc. | 4.55 Million AUD | -399.883% |
| Orthocell Limited | 15.36 Million AUD | -48.153% |
| PharmAust Limited | 6.65 Million AUD | -242.054% |
| Patrys Limited | 4.93 Million AUD | -361.566% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 65.024% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -2452.337% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -108.927% |
| PYC Therapeutics Limited | 60.91 Million AUD | 62.62% |
| Race Oncology Limited | 14.77 Million AUD | -54.162% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -7509.747% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -5.008% |
| Starpharma Holdings Limited | 22.81 Million AUD | 0.199% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 91.543% |
| Tissue Repair Ltd | 6.66 Million AUD | -241.55% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -282.793% |